_id

690dacd6ccc777a4e85d09be

Ticker

AKTX

Name

Akari Therapeutics PLC

Exchange

NASDAQ

Address

22 Boston Wharf Road, Boston, MA, United States, 02210

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.akaritx.com

Description

Akari Therapeutics, Plc, an oncology company, develops next-generation antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, colon, and prostate. Its payloads include PH5, which inhibits DNA mismatch repair (MMR) and DNA damage response (DDR) to generate neoepitopes, and PH6, which inhibits DNA transcription in cancer cells and co-opted immune cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Boston, Massachusetts.

Last Close

0.3894

Volume

114939

Current Price

0.411

Change

5.54699537750384

Last Updated

2025-11-28T12:05:08.988Z

Image

data:image/webp;base64,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

Ipo Date

2015-09-21T00:00:00.000Z

Market Cap

16962922

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.19657142857142856

Sentiment Sources

7

Rating

5

Target Price

4.5333

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

2210643

Operating Income

-2210643

Interest Expense

120273

Pretax Income

-7443030

Net Income

-6361564

Eps

-19514

Dividends Per Share

-

Shares Outstanding

32614731

Income Tax Expense

-1081465

EBITDA

-7322757

Operating Margin

-

Total Other Income Expense Net

-5232386

Cash

2484000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

2946000

Property Plant Equipment

-

Total Assets

45376000

Payables

10844000

Short Term Debt

2117000

Long Term Debt

-

Total Liabilities

22689000

Equity

22687000

Depreciation

0

Change In Working Capital

-577825

Cash From Operations

-2101646

Capital Expenditures

3.68

Cash From Investing

-

Cash From Financing

1876300

Net Change In Cash

-227000

PE

0

PB

0.000005595468770661613

ROE

-28.040569489134747

ROA

-14.019666784203103

FCF

-2101649.68

Fcf Percent

-

Piotroski FScore

1

Health Score

32

Deep Value Investing Score

4

Defensive Investing Score

4.5

Dividend Investing Score

1.5

Economic Moat Investing Score

2.8

Garp Investing Score

1

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

2.5

Quality Investing Score

1.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

2210643

Quarters > 0 > income Statement > operating Income

-2210643

Quarters > 0 > income Statement > interest Expense

120273

Quarters > 0 > income Statement > pretax Income

-7443030

Quarters > 0 > income Statement > net Income

-6361564

Quarters > 0 > income Statement > eps

-19514

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

326

Quarters > 0 > income Statement > income Tax Expense

-1081465

Quarters > 0 > income Statement > EBITDA

-7322757

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-5232386

Quarters > 0 > balance Sheet > cash

2484000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

2946000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

45376000

Quarters > 0 > balance Sheet > payables

10844000

Quarters > 0 > balance Sheet > short Term Debt

2117000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

22689000

Quarters > 0 > balance Sheet > equity

22687000

Quarters > 0 > cash Flow > net Income

-6361564

Quarters > 0 > cash Flow > depreciation

0

Quarters > 0 > cash Flow > change In Working Capital

-577825

Quarters > 0 > cash Flow > cash From Operations

-2101646

Quarters > 0 > cash Flow > capital Expenditures

3.68

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1876300

Quarters > 0 > cash Flow > net Change In Cash

-227000

Quarters > 0 > ratios > PE

-19514

Quarters > 0 > ratios > PB

0.000005595468770661613

Quarters > 0 > ratios > ROE

-28.040569489134747

Quarters > 0 > ratios > ROA

-14.019666784203103

Quarters > 0 > ratios > FCF

-2101649.68

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

32

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

-

Quarters > 1 > income Statement > operating Expenses

3119000

Quarters > 1 > income Statement > operating Income

-3119000

Quarters > 1 > income Statement > interest Expense

50000

Quarters > 1 > income Statement > pretax Income

-1895000

Quarters > 1 > income Statement > net Income

-1895000

Quarters > 1 > income Statement > eps

-120.43215761042262

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

15735

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1845000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1224000

Quarters > 1 > balance Sheet > cash

2711000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

3301000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

50911000

Quarters > 1 > balance Sheet > payables

11607000

Quarters > 1 > balance Sheet > short Term Debt

1547000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

25306000

Quarters > 1 > balance Sheet > equity

25605000

Quarters > 1 > cash Flow > net Income

-1895000

Quarters > 1 > cash Flow > depreciation

0

Quarters > 1 > cash Flow > change In Working Capital

-416000

Quarters > 1 > cash Flow > cash From Operations

-3256000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

3381000

Quarters > 1 > cash Flow > net Change In Cash

129000

Quarters > 1 > ratios > PE

-120.43215761042262

Quarters > 1 > ratios > PB

0.0002392973637961336

Quarters > 1 > ratios > ROE

-7.400898262058192

Quarters > 1 > ratios > ROA

-3.7221818467521754

Quarters > 1 > ratios > FCF

-3256000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

37

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

25998

Quarters > 2 > income Statement > cost Of Revenue

1000

Quarters > 2 > income Statement > gross Profit

-1000

Quarters > 2 > income Statement > operating Expenses

3525000

Quarters > 2 > income Statement > operating Income

-3525000

Quarters > 2 > income Statement > interest Expense

55000

Quarters > 2 > income Statement > pretax Income

-3705000

Quarters > 2 > income Statement > net Income

-3705000

Quarters > 2 > income Statement > eps

-271.4882391734447

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

13647

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-3650000

Quarters > 2 > income Statement > operating Margin

-13558.735287329797

Quarters > 2 > income Statement > total Other Income Expense Net

-180000

Quarters > 2 > balance Sheet > cash

2582000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

201000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

3349000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

50959000

Quarters > 2 > balance Sheet > payables

13067000

Quarters > 2 > balance Sheet > short Term Debt

1846000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

29213000

Quarters > 2 > balance Sheet > equity

21746000

Quarters > 2 > cash Flow > net Income

-3705000

Quarters > 2 > cash Flow > depreciation

1000

Quarters > 2 > cash Flow > change In Working Capital

567000

Quarters > 2 > cash Flow > cash From Operations

-2150000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

382000

Quarters > 2 > cash Flow > cash From Financing

2133000

Quarters > 2 > cash Flow > net Change In Cash

-17000

Quarters > 2 > ratios > PE

-271.4882391734447

Quarters > 2 > ratios > PB

0.00024437330083693554

Quarters > 2 > ratios > ROE

-17.037616113308193

Quarters > 2 > ratios > ROA

-7.270550834984987

Quarters > 2 > ratios > FCF

-2150000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-82.69866912839449

Quarters > 2 > health Score

24

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

4295000

Quarters > 3 > income Statement > operating Income

-4295000

Quarters > 3 > income Statement > interest Expense

124000

Quarters > 3 > income Statement > pretax Income

-3772000

Quarters > 3 > income Statement > net Income

-3772000

Quarters > 3 > income Statement > eps

-0.00007091969292128014

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

53186919523

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

646000

Quarters > 3 > balance Sheet > cash

2599000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

2952000

Quarters > 3 > balance Sheet > property Plant Equipment

-

Quarters > 3 > balance Sheet > total Assets

50562000

Quarters > 3 > balance Sheet > payables

12407000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

28333000

Quarters > 3 > balance Sheet > equity

22229000

Quarters > 3 > cash Flow > net Income

-3772000

Quarters > 3 > cash Flow > depreciation

1000

Quarters > 3 > cash Flow > change In Working Capital

1543000

Quarters > 3 > cash Flow > cash From Operations

-2124000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

2154000

Quarters > 3 > cash Flow > net Change In Cash

413000

Quarters > 3 > ratios > PE

-0.00007091969292128014

Quarters > 3 > ratios > PB

931.7102191846777

Quarters > 3 > ratios > ROE

-16.9688245085249

Quarters > 3 > ratios > ROA

-7.460147937186029

Quarters > 3 > ratios > FCF

-2124000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

25

Valuation > metrics > PE

-19514

Valuation > metrics > PB

0.000005595468770661613

Valuation > final Score

70

Valuation > verdict

100.0% Undervalued

Profitability > metrics > ROE

-28.040569489134747

Profitability > metrics > ROA

-215.93903598099118

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.000088156212809

Risk > metrics > Interest Coverage

-18.380210022199496

Risk > final Score

-44

Risk > verdict

High

Liquidity > metrics > Current Ratio

0.22729727644471878

Liquidity > metrics > Quick Ratio

0.22729727644471878

Liquidity > final Score

21

Liquidity > verdict

Weak

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

0

Prev Profitabilities > 2

15

Prev Risks > 0

-202

Prev Risks > 1

-226

Prev Risks > 2

-109

Prev Liquidities > 0

23

Prev Liquidities > 1

21

Prev Liquidities > 2

22

Updated At

2025-12-16T11:30:30.163Z